MEDICAL ONCOLOGY Clinical value of circulating tumor cells in breast cancer

Stefan Sleijfer, John Foekens

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)


In a trial in patients with metastatic breast cancer, the prognostic value of the number of circulating tumor cells (CTCs) at baseline was independent of tumor subtype, except in patients with HER2-positive disease treated with anti-HER2 targeted therapy. These data support the use of CTC detection as a tool contributing to personalized medicine.
Original languageUndefined/Unknown
Pages (from-to)696-698
Number of pages3
JournalNature Reviews Clinical Oncology
Issue number12
Publication statusPublished - 2011

Research programs

  • EMC MM-03-86-01

Cite this